NASDAQ:QNCX | Income Statement | Quince Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$5.46M$79.78M-$79.78M$75,000.00-$75.49M-$12.31-$12.316,132,8456,132,845
2026-03-31$6.85M$14.59M-$14.59M-$5.34M$35.91M$3.60$2.889,120,2679,190,354
2025-12-31$12.6M$19.35M-$19.35M$3.15M-$39.46M-$0.76-$0.761,862,5911,862,591
2025-09-30$8.08M$13.43M-$13.43M-$46,000.00-$13.44M-$0.25-$0.2553,951,37153,951,371
2025-06-30$6.55M$10.43M-$10.43M$67,000.00-$16.05M-$68.75-$68.75233,431233,431
2025-03-31$8.15M$14.86M-$14.86M-$14.98M$47,000.00-$15.03M-$3.42-$3.424,394,1194,394,119
2024-12-31$5.83M$12.01M-$12.01M$7,000.00-$12.46M-$0.28-$0.28171,637171,637
2024-09-30$4.92M$5.86M-$5.86M$13,000.00-$5.49M-$0.13-$0.1343,164,13643,164,136
2024-06-30$4.15M$28.19M-$28.19M$36,000.00-$27.73M-$0.64-$0.6443,096,37443,096,374
2024-03-31$3.7M$11.22M-$11.22M-$11.12M$31,000.00-$11.15M-$0.26-$0.2643,010,21243,010,212
2023-12-31$3.43M$9.92M-$9.92M$51,000.00-$8.89M-$0.21-$0.211,295,9151,295,915
2023-09-30$1.43M$6.09M-$6.09M$0.00-$5.35M-$0.15-$0.1536,073,04036,073,040
2023-06-30$1.35M$5.58M-$5.58M$0.00-$4.89M-$0.14-$0.1435,917,59235,917,592
2023-03-31$3.23M$12.96M-$12.96M-$248,000.00-$12.25M-$0.34-$0.3435,855,20035,855,200
2022-12-31$2.77M$6.32M-$6.32M$0.00-$5.53M-$0.13-$0.13738,402738,402
2022-09-30$2.45M$7.62M-$7.62M$0.00-$7.92M-$0.22-$0.2235,612,74935,612,749
2022-06-30$7.2M$16.26M-$16.26M-$284,000.00-$16.56M-$0.51-$0.5132,467,00032,467,000
2022-03-31$12.76M$21.86M-$21.86M$0.00-$21.64M-$0.72-$0.7230,134,44530,134,445
2021-12-31$15.21M$23.54M-$23.54M$0.00-$23.4M-$0.78-$0.7881,17881,178
2021-09-30$14.04M$21.68M-$21.68M$0.00-$21.71M-$0.73-$0.7329,767,37629,767,376
2021-06-30$14.72M$21.78M-$21.78M$0.00-$21.75M-$0.74-$0.7429,587,35229,587,352
2021-03-31$16.82M$23.31M-$23.31M-$23.09M29,554,921
2020-12-31$15.86M$20.85M-$20.85M-$20.56M110,226
2020-09-30$16.98M$21.91M-$21.91M-$21.51M29,488,739
2020-06-30$14.09M$18.27M-$18.27M-$17.61M29,442,915
2020-03-31$14.38M$17.86M-$17.86M-$17.18M28,261,719
2019-12-31$10.03M$12.95M-$12.95M-$12.38M3,542,724
2019-09-30$8.25M$10.57M-$10.57M-$9.86M26,841,149
2019-06-30$7.11M$9.58M-$9.58M-$9.06M15,849,189
2019-03-31$4.83M$6.08M-$6.08M-$5.68M3,521,045
2018-12-31$3.1M$3.84M-$3.84M-$3.47M1,509
2018-09-30$2.29M$2.87M-$2.87M-$2.52M3,361,029
2018-06-30$2.29M$2.64M-$2.64M-$3.11M3,360,109
2018-03-31$2.41M$2.76M-$2.76M-$3.38M3,359,989

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$35.38M$58.07M-$58.07M-$80.77M$3.21M-$83.98M-$1.68-$1.6850,096,89750,096,897
2024-12-31$18.59M$57.29M-$57.29M-$56.74M$87,000.00-$56.83M-$1.31-$1.3143,262,26943,262,269
2023-12-31$9.45M$34.62M-$34.62M-$31.58M-$197,000.00-$31.39M-$0.84-$0.8437,237,14937,237,149
2022-12-31$25.18M$52.02M-$52.02M-$51.94M-$284,000.00-$51.66M-$1.54-$1.5433,496,53433,496,534
2021-12-31$60.8M$90.32M-$90.32M-$89.95M$0.00-$89.95M-$3.03-$3.0329,718,50629,718,506
2020-12-31$61.31M$78.89M-$78.89M-$76.85M$0.00-$76.85M29,176,232
2019-12-31$30.21M$39.17M-$39.17M-$36.98M$0.00-$36.98M19,031,940
2018-12-31$10.09M$12.12M-$12.12M$0.00-$12.48M3,362,192

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.